evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract
5685,GENE_BACKGROUND,,"BBC3 (BCL2 binding component 3, also known as PUMA) is a pro-apoptotic BCL-2 family protein. BBC3 contains a BH3 (BCL-2 homology 3) domain, which allows for binding to anti-apoptotic BCL2 family members, including BCL-xL and BCL-2. This releases the pro-apoptotic factors BAK and BAX, which in turn triggers apoptosis by permeabilization of the mitochondrial membrane (PMID: 11463392, 17322918). BBC3 is a transcriptional target of p53, but it is also activated independently of p53 in response to cellular stress; thus, BBC3 is considered both a p53-dependent and -independent pro-apoptotic factor (PMID: 14585359, 19641508). Although methylation-dependent silencing has been described in Burkitt lymphomas, genetic or epigenetic inactivation of BBC3 is not commonly found in human cancers (PMID: 17267315, 18573879). However, BBC3 function can be altered as a consequence of perturbations of other factors in the apoptosis pathways, such as mutations in TP53 which abrogate its ability to induce BBC3 expression (PMID: 21478674). BBC3 is a highly efficient effector of apoptosis in model systems and the BH3 domain of BBC3 and other pro-survival BCL-2 family proteins is being investigated as a therapeutic option in the shape of BH3 mimetic peptides and small molecules (PMID: 17921043, 11463391, 19641508).",,2017-01-09,,27113,BBC3,BCL2 binding component 3,False,ENST00000449228,NM_001127240.2,JFY-1,JFY1,PUMA,False,14585359,Puma is an essential mediator of p53-dependent and -independent apoptotic pathways.,Cancer cell,2018-10-01T20:03:00,4,4,321-8,Jeffers JR et al,,,0001-10-01,,19641508,"PUMA, a potent killer with or without p53.",Oncogene,2017-12-01T20:08:00,27 Suppl 1,,S71-83,Yu J et al,doi: 10.1038/onc.2009.45,,0001-12-01,,18573879,Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis.,Molecular and cellular biology,2018-09-01T20:08:00,28,17,5391-402,Garrison SP et al,doi: 10.1128/MCB.00907-07,,2018-09-01T04:02:00,,11463392,"PUMA, a novel proapoptotic gene, is induced by p53.",Molecular cell,2018-03-01T20:01:00,7,3,683-94,Nakano K et al,,,0001-03-01,,17322918,The Bcl-2 apoptotic switch in cancer development and therapy.,Oncogene,2018-02-26T20:07:00,26,9,1324-37,Adams JM et al,,,0001-02-26,,11463391,PUMA induces the rapid apoptosis of colorectal cancer cells.,Molecular cell,2018-03-01T20:01:00,7,3,673-82,Yu J et al,,,0001-03-01,,17267315,Immunohistochemical analysis of pro-apoptotic PUMA protein and mutational analysis of PUMA gene in gastric carcinomas.,Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,2018-03-01T20:07:00,39,3,222-7,Yoo NJ et al,,,0001-03-01,,21478674,Chek2ing out the p53 pathway: can Puma lead the way?,"Cell cycle (Georgetown, Tex.)",2018-05-15T20:11:00,10,10,1524,Hollstein M et al,,,0001-05-15,,17921043,BH3 mimetics to improve cancer therapy; mechanisms and examples.,Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy,2017-12-01T20:07:00,10,6,207-17,Zhang L et al,,,0001-12-01,
5684,GENE_SUMMARY,,"BBC3, a pro-apoptotic protein, is infrequently altered in cancer.",,2017-10-23,,27113,BBC3,BCL2 binding component 3,False,ENST00000449228,NM_001127240.2,JFY-1,JFY1,PUMA,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
